Table 1.
Baseline characteristics of patients with electrolyte and acid-base disorder.
| Characteristics | N | (%) |
|---|---|---|
| Gender | ||
| Female | 51 | (62) |
| Male | 31 | (38) |
| Underlying infection | ||
| Non-tuberculous respiratory infection * | 23 | (28) |
| Tuberculosis | 17 | (21) |
| Abdominal infection | 13 | (16) |
| Urinary tract infection | 11 | (13) |
| Infection associated with neutropenia ☩ | 5 | (6.1) |
| Other | 13 | (16) |
| Antimicrobial agent | ||
| Gentamicin | 37 | (45) |
| Tobramycin | 11 | (13) |
| Capreomycin | 8 | (9.8) |
| Kanamycin | 4 | (4.9) |
| Viomycin | 2 | (2.4) |
| Colistin | 2 | (2.4) |
| Unspecified aminoglycoside ◆ | 12 | (15) |
| Other | 6 | (7.3) |
| Previous antimicrobial therapy courses | 24 | (29) |
| Duration of antimicrobial therapy ✙ | ||
| ≤1 week | 11 | (15) |
| 2–4 weeks | 37 | (50) |
| 2–6 months | 17 | (23) |
| >6 months | 9 | (12) |
| Main findings | ||
| Neuromuscular irritability | 42 | (52) |
| Muscle weakness | 2 | (2.4) |
| Irritability and weakness | 11 | (13) |
Data are presented as median (with interquartile range) or as frequency (with percentage) * 15 patients were affected by cystic fibrosis; ☩ induced by anticancer therapy; ◆ reference #24; ✙ information not available in 8 cases.